119 related articles for article (PubMed ID: 2897973)
21. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
[TBL] [Abstract][Full Text] [Related]
22. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
23. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
[TBL] [Abstract][Full Text] [Related]
24. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
Jorgensen EV; Schwartz ID; Hvizdala E; Barbosa J; Phuphanich S; Shulman DI; Root AW; Estrada J; Hu CS; Bercu BB
J Pediatr Endocrinol; 1993; 6(2):131-42. PubMed ID: 8102303
[TBL] [Abstract][Full Text] [Related]
25. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
26. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
[TBL] [Abstract][Full Text] [Related]
27. Somatostatinoma syndrome is clinically diagnosed.
Am Fam Physician; 1979 Dec; 20(6):140, 145. PubMed ID: 229723
[No Abstract] [Full Text] [Related]
28. Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study.
Saleri R; Giustina A; Tamanini C; Valle D; Burattin A; Wehrenberg WB; Baratta M
Neuroendocrinology; 2004; 79(4):221-8. PubMed ID: 15153755
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
[TBL] [Abstract][Full Text] [Related]
30. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
31. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
Ikuyama S; Nawata H; Kato K; Ibayashi H; Nakagaki H
J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
[TBL] [Abstract][Full Text] [Related]
32. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man.
Williams TC; Kelijman M; Crelin WC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Jan; 66(1):39-45. PubMed ID: 2891721
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin.
Pontiroli AE; Lanzi R; Monti LD; Sandoli E; Pozza G
J Clin Endocrinol Metab; 1991 Feb; 72(2):492-5. PubMed ID: 1671389
[TBL] [Abstract][Full Text] [Related]
35. [Somatostatinomas].
Pinsard D; Chadenas D
Diabete Metab; 1988; 14(1):43-59. PubMed ID: 2899036
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
[TBL] [Abstract][Full Text] [Related]
39. Malignant pancreatic somatostatinoma in a patient with dermatitis herpetiformis and coeliac disease.
Levi S; Bjarnason I; Swinson CM; Polak JM; Murray W; Levi AJ
Digestion; 1988; 39(1):1-6. PubMed ID: 2899527
[TBL] [Abstract][Full Text] [Related]
40. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
